A longer hospital stays usually results in higher cost and sometimes it may be detrimental for the mental health of patients. The introduction of a near-patient, extra laboratory testing, also known as Point of Care (PoC) Diagnostics made a huge impact on modern healthcare. Tangible benefits such as improvement in overall efficiency with the use of a single device and reduced cost are responsible for a surge in the adoption of PoC diagnostics. These point of care tests supports faster decision making and ensures more effective care of patients in the emergency department as well as trauma care. Higher efficiency and simplicity of Point of Care (PoC) diagnostics has brought revolutionary changes in the healthcare industry.
Major factors fueling the growth of the global Point of Care (POC) diagnostics market comprise a rise in the number of people detected with chronic conditions and infectious diseases. In addition to this, growing support from the government in the form of various initiatives and programs to encourage the adoption of Point of Care (POC) diagnostics is one of the key factors driving the market growth. Furthermore, rapid technological advancements in the field of Point of Care (POC) diagnostics coupled with increasing investments in R&D activities to develop cost-effective tests are further propelling the growth of the market across the globe.
The Point of Care (POC) diagnostics market is moderately competitive and has a presence of several leading players. In terms of market share, few of the leading players are dominating the market. With a growing aging population and increasing prevalence of diseases, other players are also anticipated to join the market.
AccuBioTech, Abbott Laboratories, Danaher Corporation, PTS Diagnostics, Siemens Healthineers, Becton, Instrumentation Laboratory Company, Roche Diagnostics, Dickinson and Company, Sekisui Diagnostics, and Chembio Diagnostic Systems are some of the major players in the market. Players are focusing on research and development of new products to attract consumers. For instance, BD, a global medical technology company has launched a rapid point-of-care SARS-CoV-2 diagnostic test that is specifically designed to be used with the company’s Veritor Plus system to help in identifying SARS-CoV-2.
Deep-dive Insights on Point of Care (PoC) Diagnostics Market by Polaris Market Research: https://www.polarismarketresearch.com/industry-analysis/point-of-care-poc-diagnostics-market
Attainment of client satisfaction being our motto, we at Polaris are happy to offer you multitude of reasons for why you should select us for your businesses.
Our commitment to our clients lies not only from the inception of our pre-on boarding discussions but also beyond the completion and delivery of our services.
We categorically offer custom-made/ tailored services for our syndicated research reports to provide you insights to meet the strategic requirements of your organization.
On lines of the industry best-practices, we offer our clients the finest in research and consulting services with the most reliable and accurate research findings.